Table 2.
Factors associated with type of secondary treatment for patients with ovarian cancer
| Chemotherapy and surgery N=265 |
Hospice N=199 |
No Treatment N=403 |
|
|---|---|---|---|
| Stage 3 | reference | reference | reference |
| Stage 4 | 0.69 (0.53,0.90) | 1.10 (0.77,1.59) | 0.77 (0.63,0.93) |
| Serous adenocarcinoma | 0.82 (0.55,1.23) | 1.00 (0.57,1.76) | 0.66 (0.52,0.83) |
| Other histology | reference | reference | reference |
| Elixhauser comorbidity score | 0.98 (0.96,0.99) | 1.02 (0.98,1.05) | 1.01 (0.99,1.02) |
| Charlson comorbidity score | 0.96 (0.86,1.07) | 1.07 (0.88,1.29) | 1.03 (0.88,1.21) |
| Grade 1 or 2 | reference | reference | reference |
| Grade 3 or 4 | 1.16 (0.96,1.41) | 0.65 (0.53,0.79) | 0.85 (0.68,1.07) |
| Grade unknown | 1.01 (0.59,1.73) | 0.85 (0.52,1.39) | 0.79 (0.64,0.97) |
| Age 65–69 | reference | reference | reference |
| Age 70–74 | 0.74 (0.60,0.90) | 1.03 (0.70,1.52) | 0.89 (0.63,1.24) |
| Age 75–79 | 0.56 (0.36,0.85) | 1.84 (1.08,3.15) | 0.92 (0.70,1.22) |
| Age 80 up | 0.43 (0.30,0.60) | 4.45 (2.67,7.41) | 1.24 (0.77,2.01) |
| Zip code median income (Census 2000) | 1.01 (0.93,1.10) | 0.97 (0.89,1.06) | 1.00 (0.96,1.05) |
| Urban | reference | reference | reference |
| Suburban | 0.94 (0.75,1.19) | 1.34 (1.00,1.79) | 0.86 (0.73,1.01) |
| Rural | 0.98 (0.61,1.57) | 1.58 (1.05,2.39) | 0.70 (0.50,0.97) |
| Northeast | reference | reference | reference |
| South | 0.83 (0.57,1.21) | 1.90 (1.56,2.32) | 1.02 (0.76,1.37) |
| Midwest | 0.96 (0.67,1.37) | 2.35 (2.06,2.68) | 0.76 (0.69,0.84) |
| West | 1.16 (0.88,1.51) | 1.63 (1.29,2.07) | 1.06 (0.94,1.19) |
| White | reference | reference | reference |
| Black | 1.27 (0.74,2.18) | 1.26 (0.65,2.46) | 1.64 (0.99,2.72) |
| Other minority | 0.74 (0.52,1.03) | 0.38 (0.17,0.83) | 1.55 (1.10,2.17) |
| Diagnoses year 1997 | reference | reference | reference |
| Diagnoses year 1998 | 1.16 (0.54,2.50) | 1.19 (0.55,2.58) | 1.64 (0.99,2.71) |
| Diagnoses year 1999 | 0.56 (0.35,0.89) | 0.63 (0.13,3.04) | 1.66 (0.65,4.29) |
| Diagnoses year 2000 | 0.69 (0.29,1.67) | 0.87 (0.41,1.84) | 1.52 (0.53,4.33) |
| Diagnoses year 2001 | 0.90 (0.48,1.67) | 1.17 (0.51,2.68) | 1.53 (0.78,3.01) |
| Diagnoses year 2002 | 0.93 (0.48,1.81) | 1.05 (0.49,2.23) | 1.68 (0.83,3.40) |
| Diagnoses year 2003 | 0.92 (0.48,1.76) | 0.70 (0.31,1.58) | 1.82 (0.85,3.92) |
| Diagnoses year 2004 | 0.98 (0.52,1.85) | 0.75 (0.41,1.38) | 2.53 (1.20,5.34) |
| Diagnoses year 2005 | 0.61 (0.26,1.46) | 0.96 (0.37,2.49) | 3.08 (1.49,6.39) |
| Diagnoses year 2006 | 0.51 (0.20,1.28) | 1.30 (0.45,3.78) | 4.78 (2.38,9.60) |
| Diagnoses year 2007 | 0.44 (0.19,0.98) | 0.43 (0.13,1.44) | 10.13 (4.89,20.95) |
Reference group: Chemotherapy only (N=1171)